Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors

Digestion

Volumn 59, Issue 2, 1998, Pages 160-166

  Kölby, Lars ^a,b   Wängberg, Bo ^a   Ahlman, Håkan ^a   Jansson, Svante ^a   Forssell Aronsson, Eva ^b   Erickson, Jeffrey D ^a   Nilsson, Ola ^a  

^a Department of Surgery ^*  (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

111In octreotide; Cell culture; Gastric carcinoid; Histamine; Histamine transporter; Somatostatin receptor subtypes

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; CORTISONE; GLUCOCORTICOID; HISTAMINE; OCTREOTIDE; PENTETATE INDIUM IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

AGED; ARTICLE; CANCER SCINTISCANNING; CARCINOID; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NORTHERN BLOTTING; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; STOMACH CANCER;

AGED; BIOLOGICAL TRANSPORT; BLOTTING, NORTHERN; CARCINOID TUMOR; FEMALE; GENE EXPRESSION; HISTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RECEPTORS, HISTAMINE; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 2642633743     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007482     Document Type: Article

References (27)

1. Askanazy M: Zur Pathogenese der Magenkrebse und über ihren gelegentlichen Ursprung aus angeborenen epithelialen Keimen in der Magenwand. Dtsch Med Wochenschr 1923;49:49-51.
2. McDonald RA: A study of 356 carcinoids of the gastrointestinal tract. Am J Med 1956;21:867.
3. Yoshino T, Ohtsuki Y, Shimada Y, Takakashi K, Senobe H, Hayashi K, Nakamura S, Motoi M, Akagi T: Multiple carcinoid tumor combined with mucosal carcinoma in the stomach. A case report. Acta Pathol Jpn 1987;37:1669-1678.
4. Sjöblom SM: Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastroenterol 1988;23:779-787.
5. Ahlman H, Kölby L, Lundell L, Olbe L, Wängberg B, Granérus G, Grimelius L, Nilsson O: Clinical management of gastric carcinoid tumors. Digstion 1994;55(suppl 3):77-85.
6. Solcia E, Fiocca R, Rindi G, Villani L, Cornaggia M, Capella C: The pathology of the gastrointestinal endocrine system. Endocrinol Metab Clin North Am 1993;22:795-821.
7. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E: Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World JSurg 1996;20:168-172.
8. Gough DB, Thompson GB, Crotty TB, Donohue JH, Kvols LK, Carney JA, Grant CS, Nagorney DM: Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994; 18: 473-479.
9. Åhlund L, Nilsson O, Kling-Petersen T, Wigander A, Theodorsson E, Dahlström A, Ahlman H: Serotonin-producing carcinoid tumour cells in long-term culture. Studies on serotonin release and morphological features. Acta Oncol 1989;28:341-346.
10. Erickson J, Schäfer M, Bonner T, Eiden L, Weihe E: Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sei USA 1996;93:5166-5171.
11. Ponzio F, Jonsson G: A rapid and simple method for the determination of picogram levels of serotonin in brain tissue using liquid chromatography with electrochemical detection. J Neurochem 1978;32:129-132.
12. Modlin IM, Kumar RR, Soroka CJ, Ahlman H, Nilsson O, Goldenring JR: Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys.DigDisScil994;39:1446-1453.
13. Wängberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjälling M, Ahlman H: Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indiumlll-labelled DTPA-O-Phe'-octreotide. Br J Cancer 1996;73:770-775.
14. Forssell-Aronsson E, Fjälling M, Nilsson O, Tisell LE, Wängberg B, Ahlman H: Indium111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. J Nucl Med 1995; 367:7-12.
15. Chomczynsky P, Sacchi N: Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Yamada Y, Post SR, Wang K, Tagcr HS, Bell GI, Seino S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sei USA1992;89:251-255.
17. Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI, Seino S: Somatostatin receptors, and expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 1992;6: 2136-2142.
18. Roher L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R: Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sei USA 1993;90:4196-4200.
19. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, et al: Cloning, functional expression and pharmacolpgical characterization of a fourth (hSSTR4) and a fifth (hSSTRS) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993; 195:844-852.
20. Capella C, Polak JM, Timson CM, Frigerio B, Solcia E: Gastric carcinoids of argyrophil ECL cells. Ultrastruct Pathol 1980;I:411-418.
21. Ahlman H, Wängberg B, Nilsson O, Grimelius L, Granérus G, Modlin IM, Stenqvist O, Scherstén T: Aspects on diagnosis and treatment of the foregut carcinoid syndrome. Scand J Gastroenterol 1992;27:459-471.
22. Fjälling M, Andersson P, Forssell-Aronsson E, Gretarsdottir J, Johanson V, Tisell LE, Wängberg B, Nilsson O, Berg G, Michanek A, Lindstedt G, Ahlman' H: Systemic radionuclide therapy using indium-111-DTPA-D-Phel-octreotide in midgut carcinoid syndrome. J Nucl Med 1996;37:1519-1521.
23. Andersson P, Forssell-Aronsson E, Johanson V, Wängeberg B, Nilsson O, Fjälling M, Ahlman H: Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-.D-Phel-octreotide. J Nucl Med 1996;37:2002-2006.
24. Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ: Somatostatin receptor scintigraphy with indium-lll-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992;33:652-658.
25. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lubbert H: Molecular pharmacology of somatostatin-receptor subtypes. Ann NY Acad Sei 1994;733:138-146.
26. Wängberg B, Westberg G, Thylén U, Tisell L, Jansson S, Nilsson O, Johanson V, Scherstén T, Ahlman H: Survival of patients with disseminated midgut carcinoid tumors after aggressive tumour reduction. World J Surg 1996;20:892-899.
27. Scherstén T, Ahlman H, Wängberg B, Grané rus G, Grimelius L: Hyperthermic liver perfusion chemotherapy in the foregut carcinoid syndrome (letter). Lancet 1991;338:568-569.